Eris MJ Biopharm

Eris MJ Biopharm is a joint venture between Eris Lifesciences and MJ Biopharm, established to expand Eris's presence in the insulin and glargine market. The company focuses on the manufacturing and commercialization of human insulin and insulin analogues, leveraging MJ Biopharm's established biopharmaceutical manufacturing capabilities and Eris's extensive marketing network in India. Its product portfolio includes various formulations of human insulin and insulin glargine, targeting the growing diabetic population. By integrating research, development, and large-scale production, Eris MJ Biopharm aims to provide affordable and high-quality biologic treatments for diabetes management.